181 related articles for article (PubMed ID: 30105548)
1. ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer.
Huang J; Sun Y; Chen H; Liao Y; Li S; Chen C; Yang Z
Gastric Cancer; 2019 Mar; 22(2):287-301. PubMed ID: 30105548
[TBL] [Abstract][Full Text] [Related]
2. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
3. Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway.
Wang N; Chang LL
Hum Cell; 2020 Jul; 33(3):663-675. PubMed ID: 32409959
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer.
Li J; Liao Y; Huang J; Sun Y; Chen H; Chen C; Li S; Yang Z
J Cancer Res Clin Oncol; 2018 Feb; 144(2):215-227. PubMed ID: 29143120
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer.
Gu J; Chen J; Feng J; Liu Y; Xue Q; Mao G; Gai L; Lu X; Zhang R; Cheng J; Hu Y; Shao M; Shen H; Huang J
Tumour Biol; 2016 Jul; 37(7):8681-9. PubMed ID: 26738863
[TBL] [Abstract][Full Text] [Related]
6. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
7. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 suppresses the migration and invasion of gastric cancer by regulating ARHGAP5 expression.
Dong G; Wang B; An Y; Li J; Wang X; Jia J; Yang Q
Cell Death Dis; 2018 Sep; 9(10):977. PubMed ID: 30250020
[TBL] [Abstract][Full Text] [Related]
9. Reduced Kiss‑1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells.
Li C; Yuan L; Han S; Xuan M; Liu D; Tian B; Yu W
Oncol Rep; 2020 Sep; 44(3):1149-1157. PubMed ID: 32705229
[TBL] [Abstract][Full Text] [Related]
10. Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells.
Wang H; Chen H; Jiang Z; Lin Y; Wang X; Xiang J; Peng J
Pathol Res Pract; 2019 Sep; 215(9):152531. PubMed ID: 31320250
[TBL] [Abstract][Full Text] [Related]
11. Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma.
Li C; Xiong Y; Yang X; Wang L; Zhang S; Dai N; Li M; Ren T; Yang Y; Zhou SF; Gan L; Wang D
Drug Des Devel Ther; 2015; 9():1773-83. PubMed ID: 25848214
[TBL] [Abstract][Full Text] [Related]
12. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
13. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
14. miR-215 promotes cell migration and invasion of gastric cancer by targeting Retinoblastoma tumor suppressor gene 1.
Chen Z; Liu K; Li L; Chen Y; Du S
Pathol Res Pract; 2017 Aug; 213(8):889-894. PubMed ID: 28689850
[TBL] [Abstract][Full Text] [Related]
15. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
[TBL] [Abstract][Full Text] [Related]
18. JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients.
Qian J; Zhu W; Wang K; Ma L; Xu J; Xu T; Røe OD; Li A; Zhou J; Shu Y
Oncotarget; 2016 Jun; 7(24):36865-36884. PubMed ID: 27167206
[TBL] [Abstract][Full Text] [Related]
19. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
20. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
Tao Y; Sun C; Zhang T; Song Y
Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
